Categories: Business

Eviva Partners Launches New Think Tank, Exposes Attack on Aluminum-Containing Vaccines

NEW YORK, July 30, 2025 /PRNewswire/ — Eviva Partners, a nonprofit organization dedicated to strengthening public understanding of medical evidence, is proud to announce the launch of Protecting Our Health (POH), a new think tank that brings together international experts in communication, public health and misinformation to confront the rise of pseudoscience.

- Advertisement -

“Medical research has generated a tremendous number of evidence-based interventions, but these are not universally adopted, leading to gaps in care,” said Eviva CEO and founder Alex Morozov, a physician-scientist, writer and former pharmaceutical executive. “Our goal is to empower people to make evidence-based decisions. This is more important now than ever. POH was launched to counteract the assault on science and health — and to reach people before deceptive tactics take hold.”

- Advertisement -

Eviva and POH are grounded in three principles:

- Advertisement -
  • Bringing the public back to science: POH aims to empower individuals to distinguish solid medical evidence from pseudoscience.
  • Inclusion: Understanding the needs of diverse communities and empowering them through evidence and two-way communication.
  • No industry funding, ever: Eviva is currently self-funded and is building a coalition of philanthropists.

On Sunday, MSNBC published an op-ed by Morozov, leading vaccinologist Dr. Helen Petousis-Harris and Eviva board member Professor Stephan Lewandowsky.

- Advertisement -

Robert F. Kennedy Jr. and others … appear to be orchestrating a strategic attack on aluminum-containing vaccines,” the op-ed says.

- Advertisement -

But the science does not support aluminum as the culprit. In a major new study involving more than 1.2 million children, Danish researchers found no link between aluminum in vaccines and 50 chronic diseases, including autism.

- Advertisement -

The op-ed warns: “If anti-vaccine activists successfully undermine aluminum-containing vaccines despite research findings like the Danish study, the consequences will be catastrophic. Vaccine-preventable diseases — such as diphtheria, meningitis, hepatitis and cancers of the liver, cervix and penis — will bounce back, causing tremendous death and suffering. And rates of autism will remain unchanged, as they have for decades.”

- Advertisement -

Protecting Our Health is not just a campaign. It is a call to action. By combining evidence, storytelling and community engagement, Eviva and POH seek to undo the damage caused by misinformation and chart a path forward — one rooted in evidence, empowerment and health for all.

- Advertisement -

To learn more or to support the campaign, visit www.evivapartners.org.

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/eviva-partners-launches-new-think-tank-exposes-attack-on-aluminum-containing-vaccines-302517718.html

- Advertisement -
PRNW Agency

Recent Posts

IOC Joins Sport for Refugees Coalition in a Call to Strengthen the Role of Sport in Refugee Responses

12 December 2025 - The International Olympic Committee (IOC) and Olympic Refuge Foundation (ORF) have joined more than…

41 minutes ago

Olympic Summit reaffirms athletes fundamental rights to access sport without political interference

11 December 2025 - The leading representatives of the Olympic Movement met today for the…

41 minutes ago

Formula 1 Etihad Airways Abu Dhabi Grand Prix brings 339,000 fans to Yas Island

ABU DHABI, UAE, Dec. 12, 2025 /PRNewswire/ -- Ethara, the organisers of the Formula 1®…

3 hours ago

From ‘Make in India’ to ‘Design for India’: Ajay Piramal Charts a Vision for Nation-Building at Anant National University

AHMEDABAD, India, Dec. 12, 2025 /PRNewswire/ -- Anant National University celebrated its 7th Convocation, awarding…

3 hours ago

ProPharma Expands Operations with New Office in Hyderabad

Modern workspace supports continued growth and innovationRALEIGH, N.C., Dec. 11, 2025 /PRNewswire/ -- ProPharma, the…

3 hours ago